Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Dunaújváros – page 15

198 clinical trials in Dunaújváros, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Dunaújváros at a glance
198
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

198 trials in Dunaújváros

Open in trial search

Study on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Enlicitide decanoate
  • Sponsor:Merck Sharp & Dohme LLC

Study of Amivantamab and Lazertinib Combination vs. Osimertinib vs. Lazertinib for First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab
  • Sponsor:Janssen - Cilag International

Cardiac failure

Not recruiting

Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Balcinrenone
  • Sponsor:Astrazeneca AB

Study on the Effectiveness and Safety of Gliclazide MR, Dapagliflozin, and Metformin for Patients with Type 2 Diabetes Not Well Controlled with Dapagliflozin

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Institut De Recherches Internationales Servier IRIS

Study on the Effects of AZD5462 for Patients with Stable Chronic Heart Failure

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:AZD5462
  • Sponsor:Astrazeneca AB

Asthma

Not recruiting

Study on the Long-term Effects of Dupilumab in Preventing Lung Function Decline in Adults with Uncontrolled Moderate to Severe Asthma

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Dry eye+1

Not recruiting

Study on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ianalumab
  • Sponsor:Novartis Pharma AG

Rheumatoid arthritis

Not recruiting

Study on the Long-Term Safety and Effectiveness of Filgotinib for Patients with Rheumatoid Arthritis

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Study on the Effects of MBS2320 for Patients with Idiopathic Pulmonary Fibrosis (IPF)

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:MBS2320
  • Sponsor:Modern Biosciences Limited

Rheumatoid arthritis

Not recruiting

Study on Nipocalimab and Certolizumab for Patients with Active Rheumatoid Arthritis After Advanced Therapy

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Anhydrous Caffeine
  • Sponsor:Janssen - Cilag International

Dry eye+1

Not recruiting

Study on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Emtricitabine
  • Sponsor:Novartis Pharma AG

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Dunaújváros

What the registry says about research in the country

01 Cardiovascular and Stroke Research

Innovative trials focusing on atherosclerotic cardiovascular disease prevention and stroke treatment, evaluating new therapeutic approaches for reducing major cardiovascular events.

  • Primary ASCVD Prevention
  • Acute Ischemic Stroke
  • High-Risk TIA Management

Studies aim to demonstrate the effectiveness of novel compounds in preventing cardiovascular complications and improving stroke outcomes.

02 Renal and Metabolic Disorders

Research examining combination therapies for chronic kidney disease with concurrent hypertension, exploring innovative treatment approaches for better patient outcomes.

  • CKD Management
  • Hypertension Control
  • Primary Biliary Cholangitis

Trials focus on evaluating new medications to slow disease progression and improve quality of life.

03 Neurological and Pain Management

Studies investigating novel treatments for episodic migraine, focusing on preventive therapies to reduce headache frequency and severity.

  • Migraine Prevention
  • Headache Management

Research aims to develop effective preventive treatments for patients suffering from recurring migraines.

04 Gastrointestinal and Inflammatory Conditions

Clinical investigations of new therapies for ulcerative colitis, examining both short-term improvement and long-term maintenance treatments.

  • Inflammatory Bowel Disease
  • UC Management
  • Long-term Disease Control

Studies evaluate novel compounds for achieving endoscopic improvement and symptomatic remission.

05 Wound Healing and Regenerative Medicine

Innovative research utilizing stem cell therapy for treating chronic venous ulcers, focusing on wound healing in difficult-to-treat cases.

  • Chronic Wound Management
  • Regenerative Medicine
  • Venous Ulcer Treatment

Trials explore advanced therapeutic approaches for non-healing wounds using cellular treatments.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.